Odyssean »

Summit Midstream Corporation shares owned by Odyssean

Quarter-by-quarter ownership of Summit Midstream Corporation (SMC) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Summit Midstream Corporation

Tip: Access up to 7 years of quarterly data

All positions including Summit Midstream Corporation held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Midstream Corporation by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $448k 16k 28.48

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Summit Midstream Corporation

Invesco
BlackRock
Vanguard Capital Management
Eagle Global Advisors
Geode Capital Management
State Street Corporation
Charles Schwab Investment Management
Susquehanna International
Flat Footed
American Century Companies
Bank of America Corporation
Bridgeway Capital Management
Ark & Tlk Investments
Citadel Advisors
Morgan Stanley

View all funds holding Summit Midstream Corporation